Literature DB >> 14590207

Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life.

R H Benedict1, J J Mezhir, K Walsh, R G Hewitt.   

Abstract

We examined the impact of neuropsychological (NP) impairment on activities of daily living (ADLs) and quality of life in human immunodeficiency virus type-1 (HIV-1)-infected persons of low socioeconomic status (SES). Thirty-nine patients were stratified into one of three groups: cognitively normal (n = 13), mild cognitive impairment (n = 15), and moderate/severe impairment (n = 11). Quality of life was assessed with the Sickness Impact Profile and ADLs were evaluated via structured interview performed in the patient's residence. While there were no significant differences across groups on disease stage, drug use, depression, or estimated premorbid IQ, cognitively impaired patients were more likely to be unemployed and fail social planning and medication management tasks. Our study confirms a previously reported association between NP impairment and unemployment among HIV-1-infected patients. The data also extend this relationship to a low-SES sample with a high base rate of unemployment, and to instrumental activities of daily living other than work.

Entities:  

Year:  2000        PMID: 14590207

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  31 in total

1.  Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning.

Authors:  Jordan E Cattie; Katie Doyle; Erica Weber; Igor Grant; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2012-06-25       Impact factor: 2.475

2.  Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.

Authors:  Doyle E Patton; Steven Paul Woods; Donald Franklin; Jordan E Cattie; Robert K Heaton; Ann C Collier; Christina Marra; David Clifford; Benjamin Gelman; Justin McArthur; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant
Journal:  AIDS Behav       Date:  2012-11

3.  HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

Authors:  Borja Mora-Peris; Alan Winston; Lucy Garvey; Laura J Else; Robin J Shattock; Carolina Herrera
Journal:  J Antimicrob Chemother       Date:  2015-10-15       Impact factor: 5.790

4.  Retrosplenial cortical thinning as a possible major contributor for cognitive impairment in HIV patients.

Authors:  Na-Young Shin; Jinwoo Hong; Jun Yong Choi; Seung-Koo Lee; Soo Mee Lim; Uicheul Yoon
Journal:  Eur Radiol       Date:  2017-04-13       Impact factor: 5.315

5.  Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life.

Authors:  Savanna M Tierney; Steven Paul Woods; David Sheppard; Ronald J Ellis
Journal:  J Neurovirol       Date:  2018-12-10       Impact factor: 2.643

6.  The Acceptability and Potential Utility of Cognitive Training to Improve Working Memory in Persons Living With HIV: A Preliminary Randomized Trial.

Authors:  Sheri L Towe; Puja Patel; Christina S Meade
Journal:  J Assoc Nurses AIDS Care       Date:  2017-03-30       Impact factor: 1.354

7.  Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment.

Authors:  Kevin Robertson; Alan Landay; Sachiko Miyahara; Alyssa Vecchio; Mary Clare Masters; Todd T Brown; Babafemi O Taiwo
Journal:  J Neurovirol       Date:  2019-08-29       Impact factor: 2.643

8.  Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection.

Authors:  Sharon L Nichols; Grace Montepiedra; John J Farley; Patricia A Sirois; Kathleen Malee; Betsy Kammerer; Patricia A Garvie; Sylvie Naar-King
Journal:  J Dev Behav Pediatr       Date:  2012-05       Impact factor: 2.225

9.  Functional disability in medication management and driving among individuals with HIV: a 1-year follow-up study.

Authors:  April D Thames; Alyssa Arentoft; Monica Rivera-Mindt; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2012-12-14       Impact factor: 2.475

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.